BiotechTube
Home/Filamon/Graham Kelly
GK

Graham Kelly

Co‑Founder, CEO and Managing Director

Filamon

Therapeutic Areas

OncologyCardiovascularNeurologyOphthalmologyImmunology

Filamon Pipeline

DrugIndicationPhase
KESONOTIDE™Broad chronic inflammatory diseasesPreclinical
BETA‑TT8Cancer, cardiovascular disease, neuroinflammatory eye conditionsPreclinical

Leadership Team at Filamon

RE
Robert Edgley
Non‑Executive Chairman
PD
Paul De Souza
Deputy CEO, Co‑Founder and Non‑Executive Director
SM
Stephen Menzies
Non‑Executive Director
JN
Jason Nagy
Non‑Executive Director
CJ
Cameron Jones
Company Secretary and CFO
View full Filamon profile